D. E. Shaw & Co. Inc. raised its stake in HCP, Inc. (NYSE:HCP) by 19.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,487,822 shares of the real estate investment trust’s stock after acquiring an additional 558,897 shares during the quarter. D. E. Shaw & Co. Inc. owned approximately 0.73% of HCP worth $97,414,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also made changes to their positions in HCP. Cohen & Steers Inc. lifted its stake in shares of HCP by 317.6% during the 3rd quarter. Cohen & Steers Inc. now owns 16,962,610 shares of the real estate investment trust’s stock valued at $446,456,000 after buying an additional 12,900,457 shares in the last quarter. BlackRock Inc. increased its holdings in HCP by 4.1% during the 4th quarter. BlackRock Inc. now owns 46,146,172 shares of the real estate investment trust’s stock worth $1,288,861,000 after acquiring an additional 1,830,425 shares during the period. Oregon Public Employees Retirement Fund increased its holdings in HCP by 2,678.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,425,966 shares of the real estate investment trust’s stock worth $51,000 after acquiring an additional 1,374,646 shares during the period. Cullen Capital Management LLC increased its holdings in HCP by 212.0% during the 3rd quarter. Cullen Capital Management LLC now owns 1,376,670 shares of the real estate investment trust’s stock worth $36,234,000 after acquiring an additional 935,390 shares during the period. Finally, Geode Capital Management LLC increased its holdings in HCP by 11.8% during the 4th quarter. Geode Capital Management LLC now owns 7,752,843 shares of the real estate investment trust’s stock worth $216,236,000 after acquiring an additional 821,285 shares during the period. Institutional investors own 94.74% of the company’s stock.
A number of analysts recently weighed in on HCP shares. Scotiabank started coverage on shares of HCP in a report on Monday, December 10th. They set an “outperform” rating and a $32.00 target price on the stock. BMO Capital Markets reaffirmed a “buy” rating and set a $33.00 target price on shares of HCP in a report on Wednesday, February 13th. Robert W. Baird raised shares of HCP from a “neutral” rating to an “outperform” rating in a report on Monday, January 7th. TheStreet raised shares of HCP from a “c” rating to a “b-” rating in a report on Wednesday, February 13th. Finally, Zacks Investment Research raised shares of HCP from a “sell” rating to a “hold” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $28.14.
HCP (NYSE:HCP) last issued its quarterly earnings results on Wednesday, February 13th. The real estate investment trust reported $1.73 EPS for the quarter, topping the Zacks’ consensus estimate of $0.43 by $1.30. The firm had revenue of $441.92 million for the quarter, compared to analyst estimates of $445.81 million. HCP had a net margin of 57.41% and a return on equity of 18.40%. The business’s revenue for the quarter was down .3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.48 EPS. Research analysts expect that HCP, Inc. will post 1.74 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, February 28th. Stockholders of record on Tuesday, February 19th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date was Friday, February 15th. HCP’s payout ratio is 81.32%.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by WKRB News and is the property of of WKRB News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.wkrb13.com/2019/03/18/hcp-inc-hcp-shares-bought-by-d-e-shaw-co-inc.html.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Article: How the Consumer Price Index (CPI) is calculated?
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.